METRONIDAZOLE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Metronidazole Hydrochloride, and what generic alternatives are available?
Metronidazole Hydrochloride is a drug marketed by Abraxis Pharm and is included in one NDA.
The generic ingredient in METRONIDAZOLE HYDROCHLORIDE is metronidazole hydrochloride. There are eighteen drug master file entries for this compound. Additional details are available on the metronidazole hydrochloride profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METRONIDAZOLE HYDROCHLORIDE?
- What are the global sales for METRONIDAZOLE HYDROCHLORIDE?
- What is Average Wholesale Price for METRONIDAZOLE HYDROCHLORIDE?
Summary for METRONIDAZOLE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 26 |
| Clinical Trials: | 589 |
| Patent Applications: | 1,855 |
| DailyMed Link: | METRONIDAZOLE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for METRONIDAZOLE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Universitt Luzern | PHASE4 |
| Faiz ur rahman | NA |
| Medical College of Wisconsin | EARLY_PHASE1 |
Anatomical Therapeutic Chemical (ATC) Classes for METRONIDAZOLE HYDROCHLORIDE
US Patents and Regulatory Information for METRONIDAZOLE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abraxis Pharm | METRONIDAZOLE HYDROCHLORIDE | metronidazole hydrochloride | INJECTABLE;INJECTION | 070295-001 | Oct 15, 1985 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
